Lexaria Bioscience Corp (LEXX)

[Screech691]

Separately, Lexaria also announces that on March 23, 2020 it has cancelled, with the approval of the optionees, an aggregate of 3,268,000 stock options (the “Options”) having exercise prices ranging from US$0.37 to US$1.53. The Options were issued pursuant to the Company’s registered stock option plans and, as a result of such option cancellations, the Company will be terminating its 2007 Stock Option Plan as there are no longer any options issued pursuant to that plan, though other options remain granted from Lexaria’s other option plans.